CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT04886492 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2026-02-09
Summary
This is a Prospective, observational research study for patients with NMOSD under the care of a licensed neurologist. Approximately 800 patients and 35 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Conditions
Sponsors & Collaborators
-
CorEvitas
lead NETWORK
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-28
- Primary Completion
- 2099-01-31
- Completion
- 2099-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients
NCT06557174 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
NCT05061953 ·Status: RECRUITING
-
Venous Irregularities, Flow and Perfusion in MS Study
NCT01593904 ·Status: UNKNOWN
-
Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.
NCT06865274 ·Status: RECRUITING ·Phase: NA
-
A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
NCT06212245 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)
NCT04289909 ·Status: COMPLETED ·Phase: NA
-
Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression
NCT05941975 ·Status: RECRUITING ·Phase: NA
-
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT04873492 ·Status: RECRUITING ·Phase: NA
-
Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns
NCT01930799 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Study of the Effects of SHR1459 in NMOSDs Patients
NCT04670770 ·Status: COMPLETED ·Phase: PHASE2
-
The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative
NCT03480854 ·Status: COMPLETED ·Phase: NA
-
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis
NCT03632473 ·Status: COMPLETED
-
Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT05551598 ·Status: COMPLETED ·Phase: PHASE2
-
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
NCT06283524 ·Status: COMPLETED
-
Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina
NCT01080014 ·Status: COMPLETED
-
Combined Analysis of Inflammatory Biomarkers for CNS Autoimmune Diseases Diagnostic
NCT05056740 ·Status: RECRUITING
-
Swiss Multiple Sclerosis Cohort-Study
NCT02433028 ·Status: RECRUITING
-
Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)
NCT05828901 ·Status: TERMINATED
-
Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
NCT06455332 ·Status: RECRUITING ·Phase: NA
-
Characteristics and Predictors of Progression of an Egyptian Multiple Sclerosis Cohort
NCT03004794 ·Status: COMPLETED
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Feasibility and Reliability of Multimodal Evoked Potentials
NCT03686826 ·Status: COMPLETED
-
Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting
NCT03047460 ·Status: COMPLETED
-
Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis
NCT00772525 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED